This is an old revision of this page, as edited by Biochemistry&Love (talk | contribs) at 21:34, 30 April 2017 (→Unsourced: Changed indicated->labeled, since "indication" is a decision made, not a label. Cited a PL chart.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 21:34, 30 April 2017 by Biochemistry&Love (talk | contribs) (→Unsourced: Changed indicated->labeled, since "indication" is a decision made, not a label. Cited a PL chart.)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)
Ideal sources for Misplaced Pages's health content are defined in the guideline Misplaced Pages:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Beta blocker.
|
This is the talk page for discussing improvements to the Beta blocker article. This is not a forum for general discussion of the article's subject. |
|
Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL |
Archives: 1Auto-archiving period: 2 months |
Pharmacology C‑class Top‑importance | ||||||||||
|
Unsourced
Moved here per WP:PRESERVE as this is almost all unsourced. Per WP:BURDEN please do not restore without finding reliable sources, checking the content against them, and citing the sources.
- Examples
- Nonselective agents
- Propranolol
- Bucindolol (has additional α1-blocking activity)
- Carteolol
- Carvedilol (has additional α1-blocking activity)
- Labetalol (has additional α1-blocking activity)
- Nadolol
- Oxprenolol
- Penbutolol (has intrinsic sympathomimetic activity)
- Pindolol (has intrinsic sympathomimetic activity)
- Sotalol (not considered a "typical beta-blocker")
- Timolol
- β1-selective agents
Also known as cardioselective
- Acebutolol (has intrinsic sympathomimetic activity, ISA)
- Atenolol
- Betaxolol
- Bisoprolol
- Celiprolol
- Metoprolol
- Nebivolol
- β2-selective agents
- β3-selective agents
- Comparative information
- Pharmacological differences
- Agents with intrinsic sympathomimetic action (ISA)
- Acebutolol, carteolol, celiprolol, mepindolol, oxprenolol, pindolol
- Agents with greater aqueous solubility (hydrophilic beta blockers)
- Atenolol, celiprolol, nadolol, sotalol
- Agents with membrane stabilizing effect
- Acebutolol, propranolol
- Indication differences
- Agents specifically labeled for cardiac arrhythmia
- Agents specifically labeled for congestive heart failure
- Agents specifically labeled for glaucoma
- Agents specifically labeled for myocardial infarction
- Agents specifically labeled for migraine prophylaxis
Propranolol is the only agent indicated for control of tremor, portal hypertension, and esophageal variceal bleeding, and used in conjunction with α-blocker therapy in phaeochromocytoma.
References
- ^ "Comparison of Oral Beta-Blockers". pharmacist.therapeuticresearch.com. Therapeutic Research Center. Retrieved 30 April 2017.
- Rosendorff C (1993). "Beta-blocking agents with vasodilator activity". Journal of Hypertension. Supplement. 11 (4): S37–40. doi:10.1097/00004872-199306003-00009. PMID 8104240.
- "Drugs to Prevent Migraine in Adults". pharmacist.therapeuticresearch.com. Therapeutic Research Center. Retrieved 30 April 2017.
- Cite error: The named reference
Rossi
was invoked but never defined (see the help page).